Investment portfolio.
We provide smart capital for Belgian innovation and driving socio-economic growth.
Our role is to create
sustainable long-term value.
all our investments are driven by our values.
CHINA BELGIUM DIRECT EQUITY INVESTMENT FUND (CBDEIF)
Détention du capital8.50 %
The investment fund invests in Chinese and Belgian companies which are established in China, or which want to set up in China.
CIM CAPITAL RESTRUT FUND
Détention du capital19.90 %
CIM Capital is an Antwerp-based holding company specialised in corporate restructuring. CIM Capital provides assistance to companies that have encountered difficulties and financial, but also operational, reinforcement.
CISSOID
Détention du capital16.86 %
Cissoid is a company that is active in de field of design and sale of semiconductors and integrated circuits that resists to extreme temperatures. It designs, develops and commercializes these products. The company gives also advise in this line of products and solutions.
Cityforward
Détention du capital49.5 %
COMET SAMBRE
The company is active in recycling ferrous and non-ferrous metals for the preparation and sale of secondary raw materials designed for the steel and metal industries.
COMET TRAITEMENTS
The company is active in recycling ferrous and non-ferrous metals for the preparation and sale of secondary raw materials designed for the steel and metal industries.
CONGRESPALEIS / PALAIS DES CONGRÈS "SQUARE"
Détention du capital100 %
Congrespaleis/Palais des Congrès organises meetings, congresses, exhibitions, trade shows and events in its buildings in Brussels.
DATANG - FPIM/SFPI VENTURE CAPITAL FUND
Détention du capital45.00 %
Investment fund, which SFPIM has set up together with the Chinese Datang group in order to promote venture capital in China.
E-HEALTH VENTURE
Détention du capital0.00 %
Ecosystem specialised in the field of e-health.
ENDO TOOLS THERAPEUTICS
Détention du capital9.61 %
Endo Tools Therapeutics (ETT) focuses on the fight against obesity by providing a procedure performable by a gastroenterologist so as to reduce the stomach by suturing its inner wall (no operation).
EPICS THERAPEUTICS
Détention du capital13.39 %
Epics Therapeutics is one of the world's first companies in the field of therapeutic RNA epigenetics. It aims to become a leader in the development of small molecules capable of correcting certain physiological imbalances caused by aberrant RNA epigenetic modifications that lead to cancer.
EPIMÈDE
Détention du capital20.00 %
The Epimède Company is a fund established as a “PRICAF” which invests in venture capital in small and medium sized technology companies, mainly in the Walloon Region, allowing them to grow.